Human Vaccines and Their Importance to Public Health

Procedia in Vaccinology

Volumn 5, Issue , 2011, Pages 120-126

  Schuchat, Anne ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Epidemiology; Immunization; Infectious diseases; Public health; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; VACCINE; VARICELLA ZOSTER VACCINE;

ARTICLE; COST CONTROL; DIARRHEA; HOSPITALIZATION; HUMAN; INFECTION CONTROL; LIFESPAN; MASS IMMUNIZATION; MEASLES; MEASLES VACCINATION; MORTALITY; PATIENT ADVOCACY; PNEUMONIA; POLIOMYELITIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH; RUBELLA; UNITED STATES;

EID: 84555190332     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2011.10.008     Document Type: Article

References (27)

1. Roush SW, Murphy TV. Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007;298:2155-63.
2. Offit PA. The Cutter Incident: How America's First Polio Vaccine Led to the Growing Vaccine Crisis. New Haven, CT: Yale University Press, 2005.
3. Centers for Disease Control. International notes certification of poliomyelitis eradication-the Americas, 1994. MMWR 1994;43:720-22.
4. de Quadros CA, Hersh BS, Olivé JM, Andrus JK, da Silveira CM, Carrasco PA. Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988-1995. J Infect Dis 1997; 175(suppl 1):S37-S42.
5. Dowdle WR, Hopkins DR (eds). The Eradication of Infectious Diseases. West Sussex, England: Wiley, 1998.
6. Keja K, Chan C, Hayden G, Henderson RH. Expanded programme on immunization. World Health Stat Q 1988;41:59-63.
7. Smith JC, Snider DE, Pickering LK, Advisory Committee on Immunization Practices. Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices. Ann Intern Med 2009;150:45-49.
8. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months - United States, 2008. MMWR 2009;58:921-26.
9. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. MMWR 2010;59:1018-23.
10. Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, et al. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adolesc Med 2005;159:1136-44.
11. Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000;283:1460-68.
12. Ray GT, Pelton SI, Klugman KP, Strutton DR, Moore MR. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States. Vaccine 2009;27:6483-94.
13. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201:32-41.
14. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010;201:1617-24.
15. Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics 2007;119:e22-e29.
16. Sugerman DE, Barskey AE, Delea MG, Ortega-Sanchez IR, Bi D, Ralston KJ, et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 2010;125:747-55.
17. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 2009;360:1981-88.
18. Feikin DR, Lexotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 2000;284:3145-50.
19. Centers for Disease Control and Prevention. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. MMWR 2010;59:657-61.
20. Centers for Disease Control and Prevention. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. MMWR 2009;58:1351-56.
21. Freed GL, Cowan AE, Clark SJ. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics 2009; 124(suppl 5):S466-S471.
22. Lee GM, Santoli JM, Hannan C, Messonnier ML, Sabin JE, Rusinak D, et al. Gaps in vaccine financing for underinsured children in the United States. JAMA 2007;298:638-43.
23. Nowalk MP, Zimmerman RK, Tabbarah M, Raymund M, Jewell IK. Determinants of adult vaccination at inner-city health centers: a descriptive study. BMC Fam Pract 2006;7:2.
24. Centers for Disease Control and Prevention. Interim Results: Influenza A (H1N1) 2009 Monovalent Vaccination Coverage --- United States, October - December 2009. MMWR 2010; 59(Early release):1-5.
25. Centers for Disease Control and Prevention. Update: Influenza Activity --- United States, 2009-10 Season. MMWR 2010;59(29):901-908.
26. Centers for Disease Control and Prevention. Notice to Readers: Final 2009 Reports of Nationally Notifiable Infectious Diseases. MMWR 2010;59(32):1025-1039.
27. GAVI Alliance, 2010. Web. 15 November 2010